Select acquires remainder of subsidiaries

By Melissa Trudinger
Tuesday, 30 November, 2004

Select Vaccines (ASX: SLT) will acquire the remaining 35 per cent of its two subsidiaries Picoral and Hepgenics from the Burnet Institute.

The institute will be issued 4 million new shares plus 2 million options in Select Vaccines in return for its equity.

Ongoing R&D programs being conducted by the Burnet Institute for the two companies will continue to be funded through December 2005.

Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...

Australian researchers have developed a portable point-of-care test that detects four common...

AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...

Content from other channels on our network

$1m custom waste management truck rolled out at K'gari

REMONDIS Australia acquires VetraHealth

Extreme weather is reshaping Australia's water systems

RMIT 'Electric Dolphin' robot removes oil spills

Energy storage tech to support WA's clean energy future

Overall public hospital performance worse than 10 years ago, report suggests

AMA Victoria releases statement after Albury Wodonga Health suspension

How healthcare providers prevent infection

Illegal work at four aged care facilities among recent prosecutions

Private services to continue at Northern Beaches Hospital until June 2027

Australian beverage sector has a record summer

AIFST and foodpro partnership in July 2026

AFGC maps out electrification pathway for manufacturers

Food distributor modernises its supply chain planning

AIP heads to Vietnam with packaging educational programs